Ian E Dixon, Managing Director, Ten Percent Owner at Tryptamine Therapeutics, holds 28.26M shares in Tryptamine Therapeutics (Ticker: AU:TYP), holds 1.77M shares in Noxopharm Ltd. (Ticker: AU:NOX). Most recently, Ian E Dixon ― shares of Tryptamine Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Ian E Dixon?
The percentage of profitable transactions made by Ian E Dixon is ―.
What is the average return per transaction made by Ian E Dixon?
The average return per transaction made by Ian E Dixon is ―.
What stocks does Ian E Dixon hold?
Ian E Dixon holds: AU:TYP, AU:NOX stocks.
What was Ian E Dixon’s latest transaction?
Ian E Dixon latest transaction was an Uninformative Buy of ―.
What was Ian E Dixon's most profitable transaction?
Ian E Dixon’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ian E Dixon's role in Tryptamine Therapeutics?
Ian E Dixon's role in Tryptamine Therapeutics is Managing Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.